{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-311319","form_type":"8-K","ticker":"NUVB","cik":"0001811063","company_name":"Nuvation Bio Inc.","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.250443+00:00","generated_at":"2026-06-28T16:56:18.816753+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Nuvation Bio terminates collaboration agreement with SPARCBIO LLC effective Jan 2022","bullets":["On Oct 22, 2021, Nuvation notified SPARCBIO LLC of termination effective Jan 21, 2022 without penalty.","The collaboration agreement was originally dated Jan 21, 2019 among Nuvation, RePharmation, and SPARCBIO LLC.","Company stated it no longer requires the services under the collaboration agreement.","No additional costs, penalties, or new agreements were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-311319","json":"https://secwatch.observer/filing/0001193125-21-311319.json","markdown":"https://secwatch.observer/filing/0001193125-21-311319.md","text":"https://secwatch.observer/filing/0001193125-21-311319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/0001193125-21-311319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811063/000119312521311319/d162622d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:56:18.816753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}